GC2501 Study Site 108 — Rochester, Minnesota

GC2501 Study Site 108 is a clinical research site located in Rochester, Minnesota, United States 55905.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

GC2501 Study Site 108 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Alpha 1 Antitrypsin Deficiency.

Sponsors: Grifols Therapeutics LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rochester

Browse all research sites in Minnesota · View every site in Rochester

• Rochester Methodist Hospital, Mayo Clinic
• University of Rochester Medical Center - Strong Memorial Hospital
• Mayo Clinic Hospital, Methodist Campus
• Mayo Clinic Rochester, Methodist Hospital Campus
• Mayo Clinic Hospital Rochester /ID# 269643
• Mayo/St. Mary's Hospital
• Mayo Clinic Foundation-Hospital
• Mayo Clinic Hospital Rochester /ID# 278995
• St. Marys Hospital/ MAYO Clinic
• Mayo Clinic Hospital
• Ohio State University Telemedicine
• Mayo Clinic Hospital - College of Medicine

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GC2501 Study Site 108?

GC2501 Study Site 108 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GC2501 Study Site 108 conducted?

GC2501 Study Site 108 has 1 clinical trials on record, with 1 currently active. Their work covers Alpha 1 Antitrypsin Deficiency.

Is GC2501 Study Site 108 accredited by Crixeo Clinical Trials?

GC2501 Study Site 108 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GC2501 Study Site 108?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.